Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ya-Lin A. Huang"'
Autor:
Jeremy A.W. Gold, Stacey Adjei, Adi V. Gundlapalli, Ya-Lin A. Huang, Tom Chiller, Kaitlin Benedict, Mitsuru Toda
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 7, Pp 1433-1437 (2023)
Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019–2021. During 2020–2021, patients hospitalized with COVID-19–associated fungal infections had higher (48.5%) in-hospital mortality rates than
Externí odkaz:
https://doaj.org/article/a63ac64a6aa94323aee7787d4ae37857
Autor:
Elizabeth C. Ailes, Weiming Zhu, Elizabeth A. Clark, Ya-lin A. Huang, Margaret A. Lampe, Athena P. Kourtis, Jennita Reefhuis, Karen W. Hoover
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
Pregnancy is a condition of broad interest across many medical and health services research domains, but one not easily identified in healthcare claims data. Our objective was to establish an algorithm to identify pregnant women and their pregnancies
Externí odkaz:
https://doaj.org/article/22e32023aaf64fc3996d21e420e8be68
Autor:
Ya-Lin A. Huang, Hussain Yusuf, Alys Adamski, Joy Hsu, James Baggs, Rehab Auf, Stacey Adjei, Rhett Stoney, W. Craig Hooper, Eloisa Llata, Emilia H. Koumans, Jean Y. Ko, Sebastian Romano, Tegan K. Boehmer, Aaron M. Harris
Publikováno v:
Journal of Thrombosis and Thrombolysis. 55:189-194
The association between thromboembolic events (TE) and COVID-19 infection is not completely understood at the population level in the United States. We examined their association using a large US healthcare database. We analyzed data from the Premier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811796ed632f93f3bda53f65dcf916bf
https://doi.org/10.1007/s11239-022-02735-0
https://doi.org/10.1007/s11239-022-02735-0
Autor:
Stephanie S Chan, Andre R Chappel, Karen E Joynt Maddox, Karen W Hoover, Ya-Lin A Huang, Weiming Zhu, Stacy M Cohen, Pamela W Klein, Nancy De Lew
Publikováno v:
PLoS Medicine, Vol 17, Iss 4, p e1003072 (2020)
BACKGROUND:In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exposure prophylaxis (PrEP) is an effective strategy that reduces the risk of HIV acquisition; however, uptake among those who can benefit from it has lag
Externí odkaz:
https://doaj.org/article/ec11971d55624da8bbb49313fb8060bd
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240727 (2020)
BackgroundThe suppression of viremia among persons with HIV (PWH) using antiretroviral therapy has been hypothesized to reduce HIV incidence at the population level. We investigated the impact of state level viral suppression among PWH in the United
Externí odkaz:
https://doaj.org/article/e9e5a37bc020482b8f6be06697fc4da6
Autor:
Weiming Zhu, Ya-lin A. Huang, Ruiguang Song, Jeffrey Wiener, Robyn N. Neblett-Fanfair, Athena P. Kourtis, Karen W. Hoover
Publikováno v:
AIDS. 37:851-853
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b087e8a628d458454e0a4fd5f47bd1a
https://doi.org/10.1097/qad.0000000000003503
https://doi.org/10.1097/qad.0000000000003503
Autor:
Ya Lin A, Huang, Weiming, Zhu, Jeffrey, Wiener, Athena P, Kourtis, H Irene, Hall, Karen W, Hoover
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Uptake of HIV pre-exposure prophylaxis (PrEP) has been increasing in the United States since its FDA approval in 2012; however, the COVID-19 pandemic may have affected this trend. Our objective was to assess the impact of COVID-19 on PrEP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a1e30e5a981eaeaa9170cab9f588fa8
https://doi.org/10.1093/cid/ciac038
https://doi.org/10.1093/cid/ciac038
Autor:
Karen W. Hoover, Weiming Zhu, Zanetta C. Gant, Kevin P. Delaney, Jeffrey Wiener, Neal Carnes, Dominique Thomas, John Weiser, Ya-Lin A. Huang, Laura W. Cheever, Athena P. Kourtis
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(48)
Increasing HIV testing, preexposure prophylaxis (PrEP), and antiretroviral therapy (ART) are pillars of the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, with a goal of decreasing new HIV infections by 90% by 2030.* In response to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f2a717426ce21099760c2dd3503401
https://pubmed.ncbi.nlm.nih.gov/36454696
https://pubmed.ncbi.nlm.nih.gov/36454696
Publikováno v:
J Acquir Immune Defic Syndr
Background The number and characteristics of pre-exposure prophylaxis (PrEP) health care providers in the United States have not been reported. Methods We analyzed a national pharmacy database that included >90% of all prescriptions dispensed by reta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0525478ef2386eeaaa159b0d77997a69
https://doi.org/10.1097/qai.0000000000002774
https://doi.org/10.1097/qai.0000000000002774
Publikováno v:
Morbidity and Mortality Weekly Report
HIV testing is a critical component of effective HIV prevention and care. CDC recommends routine opt-out HIV testing in health care settings for all sexually active persons aged 13-64 years at least once in their lifetime and risk-based testing regar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76490b649c7548fa33f726f7209d4953
https://doi.org/10.15585/mmwr.mm7025a1
https://doi.org/10.15585/mmwr.mm7025a1